The R/S is no longer a concern for me now. The bil

The R/S is no longer a concern for me now. The billion extra shares has had my full attention though as well. Just remember AMBS has access to 20 million from LPC and that would still keep us under the 1 billion outstanding shares. Especially if they make a cash draw from LPC after the stock price spikes any at all.

One take away from the Chairman's Blog last week that made me perk up too was,
"We are continuing to evaluate shareholder value creating arrangements for our diagnostics division, including a potential ‘spin-out’ or other business arrangements that would make strategic sense for the various LymPro and Amarantus stakeholders. We will not be giving additional details related to those possible arrangements in today’s business update call, as we are contractually prohibited from doing so ".

- See more at: http://www.thechairmansblog.com/amarantus-bio...0v95k.dpuf

There is no doubt this is white knuckle investing in it's truest form. But if the science proves itself, those that have the whitest knuckles will make the most cash. Hold on tight if you can afford to.